Pfizer, BioNTech COVID vaccine snatches another win in Canada

 

• Canada has become the latest country to approve the COVID-19 vaccine co-developed by Pfizer (PFE) and BioNTech (BNTX). Already approved in the U.K. and Bahrain, the vaccine, code-named BNT162b2, is undergoing the FDA review this week ahead of a potential emergency use authorization in the U.S.
• “Health Canada and the Public Health Agency of Canada will closely monitor the safety of the vaccine once it is on the market and will not hesitate to take action if any safety concerns are identified,” Health Canada said in a statement.
• The recommendation for use in people 16 years of age or older, could change as “Pfizer-BioNTech are running further clinical trials on children of all age groups”, it further added.
• Pfizer and BioNTech are on track to supply 20 million doses to Canada through 2021, including 249,000 doses scheduled to deliver this month.
• Yesterday, Britain kicked off its COVID-19 vaccination campaign giving the Pfizer/BioNTech jab to a 90-year old retired shop clerk.
• https://seekingalpha.com/news/3643002-pfizer-biontech-covid-vaccine-snatches-another-win-in-canada